Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3Unknown 2Terminated 2Recruiting 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 341Ovarian Neoplasms 177Lung Neoplasms 171Breast Neoplasms 118Fallopian Tube Neoplasms 87Neoplasms 79Carcinoma, Ovarian Epithelial 69Squamous Cell Carcinoma of Head and Neck 51Small Cell Lung Carcinoma 49Triple Negative Breast Neoplasms 41Adenocarcinoma of Lung 41Head and Neck Neoplasms 40Neoplasm Metastasis 37Neuroblastoma 34Central Nervous System Neoplasms 33Endometrial Neoplasms 28Esophageal Neoplasms 27Carcinoma 27Brain Neoplasms 27Lymphoma 26Recurrence 25Parkinson Disease 4, Autosomal Dominant Lewy Body 25Lymphoma, Large B-Cell, Diffuse 25Urinary Bladder Neoplasms 24Adenocarcinoma, Bronchiolo-Alveolar 23Testicular Neoplasms 22Astrocytoma 22Melanoma 19Uterine Cervical Neoplasms 18Prostatic Neoplasms 18

Interventions

Cisplatin 15Gemcitabine 7Fluorouracil 6Docetaxel 6Radiotherapy, Intensity-Modulated 5Oxaliplatin 4Capecitabine 4pembrolizumab 3Radiotherapy 3Carboplatin 3Acupuncture Therapy 3Psychiatric Rehabilitation 2Paclitaxel 2Nicotine 2Counseling 2Cetuximab 2Celecoxib 2Bupropion 2tislelizumab 1spartalizumab 1sargramostim 1motexafin gadolinium 1fosaprepitant 1fialuridine 1endostar protein 1cc-486 1apatinib 1Zoledronic Acid 1Zinc Oxide 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Nasopharyngeal Neoplasms × Carboplatin × Clear all
NCT02578641 2023-06-28

VANCE

Tessa Therapeutics

Phase 3 Completed
330 enrolled 18 charts
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Nose Neoplasms, Epstein-Barr Virus Infections

NCT00003206 2023-06-15

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

NCT00603915 2019-02-28

A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

University Health Network, Toronto

Phase 2 Completed
20 enrolled 8 charts
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡